The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     
 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hammaker, D. R.
Right arrow Articles by Firestein, G. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hammaker, D. R.
Right arrow Articles by Firestein, G. S.
Right arrowPubmed/NCBI databases
*Domain*Gene
*GEO Profiles*HomoloGene
*OMIM*UniGene
*Substance via MeSH
Medline Plus Health Information
*Joint Disorders
*Rheumatoid Arthritis
The Journal of Immunology, 2004, 172: 1612-1618.
Copyright © 2004 by The American Association of Immunologists

Regulation of c-Jun N-Terminal Kinase by MEKK-2 and Mitogen-Activated Protein Kinase Kinase Kinases in Rheumatoid Arthritis1

Deepa R. Hammaker, David L. Boyle, Martine Chabaud-Riou and Gary S. Firestein2

Division of Rheumatology, Allergy and Immunology, University of California, San Diego School of Medicine, La Jolla, CA 92093

The mitogen-activated protein kinase (MAPK) c-Jun N-terminal kinase (JNK) is a critical regulator of collagenase-1 production in rheumatoid arthritis (RA). The MAPKs are regulated by upstream kinases, including MAPK kinases (MAPKKs) and MAPK kinase kinases (MAP3Ks). The present study was designed to evaluate the expression and regulation of the JNK pathway by MAP3K in arthritis. RT-PCR studies of MAP3K gene expression in RA and osteoarthritis synovial tissue demonstrated mitogen-activated protein kinase/ERK kinase kinase (MEKK) 1, MEKK2, apoptosis-signal regulating kinase-1, TGF-{beta} activated kinase 1 (TAK1) gene expression while only trace amounts of MEKK3, MEKK4, and MLK3 mRNA were detected. Western blot analysis demonstrated immunoreactive MEKK2, TAK1, and trace amounts of MEKK3 but not MEKK1 or apoptosis-signal regulating kinase-1. Analysis of MAP3K mRNA in cultured fibroblast-like synoviocytes (FLS) showed that all of the MAP3Ks examined were expressed. Western blot analysis of FLS demonstrated that MEKK1, MEKK2, and TAK1 were readily detectable and were subsequently the focus of functional studies. In vitro kinase assays using MEKK2 immunoprecipitates demonstrated that IL-1 increased MEKK2-mediated phosphorylation of the key MAPKKs that activate JNK (MAPK kinase (MKK)4 and MKK7). Furthermore, MEKK2 immunoprecipitates activated c-Jun in an IL-1 dependent manner and this activity was inhibited by the selective JNK inhibitor SP600125. Of interest, MEKK1 immunoprecipitates from IL-1-stimulated FLS appeared to activate c-Jun through the JNK pathway and TAK1 activation of c-Jun was dependent on JNK, ERK, and p38. These data indicate that MEKK2 is a potent activator of the JNK pathway in FLS and that signal complexes including MEKK2, MKK4, MKK7, and/or JNK are potential therapeutic targets in RA.




This article has been cited by other articles:


Home page
 J. Biol. Chem.Home page
H. Deng, F. Yu, J. Chen, Y. Zhao, J. Xiang, and A. Lin
Phosphorylation of Bad at Thr-201 by JNK1 Promotes Glycolysis through Activation of Phosphofructokinase-1
J. Biol. Chem., July 25, 2008; 283(30): 20754 - 20760.
[Abstract] [Full Text] [PDF]

Home page
 DiabetesHome page
D. Mokhtari, J. W. Myers, and N. Welsh
MAPK Kinase Kinase-1 Is Essential for Cytokine-Induced c-Jun NH2-Terminal Kinase and Nuclear Factor-{kappa}B Activation in Human Pancreatic Islet Cells
Diabetes, July 1, 2008; 57(7): 1896 - 1904.
[Abstract] [Full Text] [PDF]

Home page
 Ann Rheum DisHome page
G Schett, J Zwerina, and G Firestein
The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis
Ann Rheum Dis, July 1, 2008; 67(7): 909 - 916.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
T. Thalhamer, M. A. McGrath, and M. M. Harnett
MAPKs and their relevance to arthritis and inflammation
Rheumatology, April 1, 2008; 47(4): 409 - 414.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
J. Wang, C. Li, Y. Liu, W. Mei, S. Yu, C. Liu, L. Zhang, X. Cao, R. P. Kimberly, W. Grizzle, et al.
JAB1 Determines the Response of Rheumatoid Arthritis Synovial Fibroblasts to Tumor Necrosis Factor-{alpha}
Am. J. Pathol., September 1, 2006; 169(3): 889 - 902.
[Abstract] [Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
H.-S. Cha, D. L. Boyle, T. Inoue, R. Schoot, P. P. Tak, P. Pine, and G. S. Firestein
A Novel Spleen Tyrosine Kinase Inhibitor Blocks c-Jun N-Terminal Kinase-Mediated Gene Expression in Synoviocytes
J. Pharmacol. Exp. Ther., May 1, 2006; 317(2): 571 - 578.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Cell. Biol.Home page
J. Cheng, D. Zhang, K. Kim, Y. Zhao, Y. Zhao, and B. Su
Mip1, an MEKK2-Interacting Protein, Controls MEKK2 Dimerization and Activation
Mol. Cell. Biol., July 15, 2005; 25(14): 5955 - 5964.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
S. E. Sweeney, D. Hammaker, D. L. Boyle, and G. S. Firestein
Regulation of c-Jun Phosphorylation by the I{kappa}B Kinase-{epsilon} Complex in Fibroblast-Like Synoviocytes
J. Immunol., May 15, 2005; 174(10): 6424 - 6430.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
J. Cheng, L. Yu, D. Zhang, Q. Huang, D. Spencer, and B. Su
Dimerization through the Catalytic Domain Is Essential for MEKK2 Activation
J. Biol. Chem., April 8, 2005; 280(14): 13477 - 13482.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2004 by The American Association of Immunologists, Inc. All rights reserved.